Central Pharmaceuticals (DHA:CENTRALPHL) Dividends per Share: BDT0.00 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:CENTRALPHL Central Pharmaceuticals Ltd DHA:CENTRALPHL
65 GF Score
Price BDT10.00
GF Value BDT12.12
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Central Pharmaceuticals Dividends per Share?

Central Pharmaceuticals DHA:CENTRALPHL -2.91% 65 Dividends per Share is BDT0.00 as of Mar. 2026. GuruFocus rates DHA:CENTRALPHL with a GF Score™ of 65/100 and a GF Value™ of BDT12.12 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Central Pharmaceuticals's dividends per share for the three months ended in Mar. 2026 was BDT0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was BDT0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00. As of today, Central Pharmaceuticals's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Central Pharmaceuticals  (DHA:CENTRALPHL) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Central Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0/ -0.09
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 13 years, the highest Dividend Yield of Central Pharmaceuticals was 1.16%. The lowest was 0.60%. And the median was 0.78%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central Pharmaceuticals Dividends per Share Related Terms

Central Pharmaceuticals Dividends per Share Historical Data

* Premium members only.

The historical data trend for Central Pharmaceuticals's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central Pharmaceuticals Dividends per Share Chart

Central Pharmaceuticals Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Dividends per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Central Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DHA:CENTRALPHL vs ZTS, UTHR, VTRS: Dividends per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Central Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Central Pharmaceuticals Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Central Pharmaceuticals's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Central Pharmaceuticals's Dividend Yield % falls into.


DHA:CENTRALPHL
65GF Score
Central Pharmaceuticals Ltd DHA:CENTRALPHL
Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Central Pharmaceuticals Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of BDT0.00 mean?
Central Pharmaceuticals (DHA:CENTRALPHL) has a Dividends per Share of BDT0.00 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Central Pharmaceuticals and its competitors.
Is Central Pharmaceuticals' Dividends per Share too high?
Central Pharmaceuticals' current Dividends per Share is BDT0.00. Overall, Central Pharmaceuticals has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Central Pharmaceuticals' Dividends per Share compare to ZTS and UTHR?
Central Pharmaceuticals' Dividends per Share of BDT0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Central Pharmaceuticals and its competitors. Central Pharmaceuticals's current Dividends per Share is BDT0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Central Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Central Pharmaceuticals (DHA:CENTRALPHL) is currently considered Modestly Undervalued. The stock's GF Value™ is BDT12.12, compared to a current price of BDT10.00 — trading 17.5% below its estimated fair value. The current Dividends per Share is BDT0.00. Central Pharmaceuticals' overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Central Pharmaceuticals (DHA:CENTRALPHL), the current Dividends per Share is BDT0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Central Pharmaceuticals (DHA:CENTRALPHL) Overvalued in 2026?

Based on GuruFocus' analysis, Central Pharmaceuticals stock appears to be undervalued. The current stock price of BDT10.00 is trading 17.5% below its estimated GF Value™ of BDT12.12. GuruFocus considers Central Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for DHA:CENTRALPHL:

  • Dividends per Share: BDT0.00
  • GF Value™: BDT12.12 vs. price of BDT10.00 (17.5% below fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the DHA:CENTRALPHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Central Pharmaceuticals Business Description

Address South West Darus Salam Road, 2-A/1, 2nd Floor, Mirpur - 1, Dhaka, BGD, 1216
Central Pharmaceuticals Ltd is engaged in the manufacturing and marketing of medicines in Bangladesh. The company manufactures finished pharmaceutical formulations, including tablets, capsules, liquids, ointments, and injectables, covering therapeutic areas such as anti-infectives, cardiovascular treatments, pain management, and gastrointestinal remedies. It conducts production and sales exclusively in the domestic market through its own facilities and distribution network. The company generates revenue from the sales of its pharmaceutical preparations.
65GF Score

Get the complete analysis for DHA:CENTRALPHL

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT10.00
Price
BDT12.12
GF Value